GLP-1 Medications for Cardiovascular Disease
Diseases of the heart and blood vessels including coronary artery disease, stroke, and heart attack. SELECT trial: semaglutide reduced major cardiac events by 20% in non-diabetic patients with CVD and obesity. Cardiovascular Disease affects 121 million US adults have some form of CVD, and GLP-1 medications offer a clinically proven treatment option.
Prevalence
121 million US adults have some form of CVD
Recommended Medications
2
Treatment Type
GLP-1 Agonist
How GLP-1 Medications Help with Cardiovascular Disease
SELECT trial: semaglutide reduced major cardiac events by 20% in non-diabetic patients with CVD and obesity. For patients with cardiovascular disease, GLP-1 medications address the underlying metabolic dysfunction that makes weight management difficult. Clinical trials have consistently shown that GLP-1 treatment produces significant improvements in both weight and condition-specific outcomes.
Recommended GLP-1 Medications for Cardiovascular Disease
Based on clinical evidence, the following GLP-1 medications are recommended for patients with cardiovascular disease:
Semaglutide
Wegovy / Ozempic
Tirzepatide
Zepbound / Mounjaro
Detailed Medication Guides for Cardiovascular Disease
Cardiovascular Disease & GLP-1 FAQ
Can GLP-1 medications help with cardiovascular disease?
Yes. SELECT trial: semaglutide reduced major cardiac events by 20% in non-diabetic patients with CVD and obesity. Clinical evidence supports the use of GLP-1 medications like semaglutide and tirzepatide for patients with cardiovascular disease.
Which GLP-1 medication is best for cardiovascular disease?
Semaglutide is often the first-line recommendation for cardiovascular disease due to its strong clinical evidence. Your provider will evaluate your specific situation to determine the best option.
How much weight can I lose with GLP-1 if I have cardiovascular disease?
Weight loss results are generally comparable to clinical trial averages (15-22% of body weight), though individual results vary based on the severity of cardiovascular disease and other health factors.
How prevalent is cardiovascular disease?
Cardiovascular Disease affects 121 million US adults have some form of CVD. GLP-1 medications represent a significant treatment advancement for patients dealing with this condition alongside excess weight.